
(CALMATTERS) – As calls mount for life to return to normal, a test to see who has immunity to COVID-19 holds the key to reopening California’s economy. But there are hurdles: Competition to procure limited tests is ramping up, even as the tests’ accuracy remains contested, the Los Angeles Times reports.
Unlike diagnostic tests, blood-based, or serology, tests don’t determine if you have the virus. They gauge if you have developed antibodies, or an immune response, to the virus. But questions remain.
- How reliable are the tests? Nearly 100 types of serology tests have entered the U.S. market due to a loosening in federal regulations. Not all are accurate. “We … have been receiving some of these kits, and we decided to test them to see how well they worked. And some of them weren’t very good,” said Yvonne Maldonado, a Stanford infectious-disease expert.
- What do antibodies mean? Even if reliable tests show someone has antibodies, that doesn’t guarantee current or long-term immunity. And researchers still don’t know if you can contract the virus more than once.
Meanwhile, components needed to expand diagnostic testing for the virus — the first step to reopen California’s economy — are in short supply, Gov. Gavin Newsom said Tuesday.
- Newsom: The Trump administration “knows this. We need more of those supplies, but we’re not just going to sit on our hands in the absence of that. … And so we’ll continue to search high and low and continue to make progress in this space.”
Support Our Work
Independent journalism needs YOUR support to survive and thrive. Help us achieve our mission of creating a more informed world by making a one-time or recurring donation today.